Skip to main content
Clinical Trials/NCT01009268
NCT01009268
Completed
Not Applicable

The Effect of a Pre- and Postoperative Orthogeriatric Service. A Randomised, Controlled Trial

Ullevaal University Hospital1 site in 1 country332 target enrollmentSeptember 2009

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Dementia
Sponsor
Ullevaal University Hospital
Enrollment
332
Locations
1
Primary Endpoint
We will use a composite endpoint by these two instruments: Clinical Dementia Rating Scale (CDR), and the 10 words memory task from the Consortium to Establish a Registry for Alzheimer's Disease battery (CERAD)
Status
Completed
Last Updated
12 years ago

Overview

Brief Summary

The investigators' aim is to assess the effect of a model of preoperative as well as early postoperative care, treatment and rehabilitation in a dedicated orthogeriatric ward in a single-blind randomised study.

The investigators' main hypothesis is that an orthogeriatric service may improve long-time cognitive outcome.

Detailed Description

The study will be carried out in close cooperation between the Orthopaedic Centre and the Department of Geriatric Medicine. The patients will be randomized in the Emergency Department in accordance with procedures already established for a recently finished trial. The intervention group will be transferred as soon as possible to the orthogeriatric ward, stabilised there preoperatively, and transferred back to the same ward postoperatively for further treatment and rehabilitation, while the control group will be treated in a traditional orthopaedic ward. Operative and anaesthesiologic procedures will be the same in the two groups. The primary endpoint is chosen in order to optimize clinical relevance as well as sensitivity to change within a wide range of functional performance, and will be recorded four months after the fracture. Our main hypothesis is that an orthogeriatric service may improve long-time cognitive outcome. Accordingly, we will use a composite endpoint tapping cognitive functioning in the lower as well as the higher spectre of performance by these two instruments: * Clinical Dementia Rating Scale (CDR), proxy-based scale for severity of dementia, that is able to detect differences also between patients with severe dementia. The scale consists of six questions, each rated 0-3, adding up to a sumscore of 0-18 ("sum of boxes"). The scale is frequently used in dementia treatment trials, and is shown to be valid and reliable. CDR will be scored based on the best available source (relative, staff in nursing home or home nursing service) * The 10 words memory task from the Consortium to Establish a Registry for Alzheimer's Disease battery (CERAD). This test is shown to be sensitive for memory changes in persons that have a good or fairly good cognitive functioning. We will use the immediate recall and the delayed recall parts of this task, i.e. two scales. The primary endpoint will be assessed after four months, by a specially trained research assistant blinded to allocation. The patients will be re-assessed after 12 months.

Registry
clinicaltrials.gov
Start Date
September 2009
End Date
December 2012
Last Updated
12 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Ullevaal University Hospital
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Eligible patients will be admitted acutely for a femoral neck fracture, a trochanteric or a subtrochanteric femoral fracture.

Exclusion Criteria

  • Hip fracture as part of multi-trauma or high energy trauma (defined as a fall from a higher level than 1 metre). One recent fracture in addition to the hip fracture (e.g. radius or shoulder) is acceptable.
  • Regarded as moribund at admittance.
  • Absence of a valid informed consent or assent.

Outcomes

Primary Outcomes

We will use a composite endpoint by these two instruments: Clinical Dementia Rating Scale (CDR), and the 10 words memory task from the Consortium to Establish a Registry for Alzheimer's Disease battery (CERAD)

Time Frame: 4 and 12 months

Secondary Outcomes

  • Markers of bone turnover(4 months)
  • Micronutrients in blood(4 months)
  • Nottingham Extended Activities of Daily Living (NEADL) scale(4 and 12 months)
  • Intrahospital mortality(4 and 12 months)
  • Cumulative mortality(4 and 12 months)
  • The Short Physical Performance Battery (SPPB) scale(4 and 12 months)
  • Pre-/postoperative delirium(4 and 12 months)
  • Activities of Daily Living (ADL) Scale(4 and 12 months)
  • Duration/Severity of delirium(4 and 12 months)
  • Other complications(4 and 12 months)
  • Incidence of dementia 12 months postoperatively(4 and 12 months)
  • Length of hospital stay(4 and 12 months)

Study Sites (1)

Loading locations...

Similar Trials